title: Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype.
authors.affiliation: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Seong Yoon
authors.initials: SY
authors.lastname: Yi
authors.forename: Jin Seok
authors.initials: JS
authors.lastname: Ahn
authors.forename: Ji Eun
authors.initials: JE
authors.lastname: Uhm
authors.forename: Do Hyoung
authors.initials: DH
authors.lastname: Lim
authors.forename: Sang Hoon
authors.initials: SH
authors.lastname: Ji
authors.forename: Hyun Jung
authors.initials: HJ
authors.lastname: Jun
authors.forename: Kyoung Ha
authors.initials: KH
authors.lastname: Kim
authors.forename: Myung Hee
authors.initials: MH
authors.lastname: Chang
authors.forename: Min Jae
authors.initials: MJ
authors.lastname: Park
authors.forename: Eun Yoon
authors.initials: EY
authors.lastname: Cho
authors.forename: Yoon La
authors.initials: YL
authors.lastname: Choi
authors.forename: Yeon Hee
authors.initials: YH
authors.lastname: Park
authors.forename: Young-Hyuck
authors.initials: YH
authors.lastname: Im